Literature DB >> 32528247

Cutaneous Aβ-Non-nociceptive, but Not C-Nociceptive, Dorsal Root Ganglion Neurons Exhibit Spontaneous Activity in the Streptozotocin Rat Model of Painful Diabetic Neuropathy in vivo.

Laiche Djouhri1, Asad Zeidan1, Seham A Abd El-Aleem2,3, Trevor Smith4.   

Abstract

Diabetic peripheral neuropathic pain (DPNP) is the most devastating complication of diabetes mellitus. Unfortunately, successful therapy for DPNP remains a challenge because its pathogenesis is still elusive. However, DPNP is believed to be due partly to abnormal hyperexcitability of dorsal root ganglion (DRG) neurons, but the relative contributions of specific functional subtypes remain largely unknown. Here, using the strepotozotocin (STZ) rat model of DPNP induced by a STZ injection (60 mg/kg, i.p), and intracellular recordings of action potentials (APs) from DRG neurons in anesthetized rats, we examined electrophysiological changes in C-and Aβ-nociceptive and Aβ-low threshold mechanoreceptive (LTM) neurons that may contribute to DPNP. Compared with control, we found in STZ-rats with established pain hypersensitivity (5 weeks post-STZ) several significant changes including: (a) A 23% increase in the incidence of spontaneous activity (SA) in Aβ-LTMs (but not C-mechanosensitive nociceptors) that may cause dysesthesias/paresthesia suffered by DPNP patients, (b) membrane hyperpolarization and a ∼85% reduction in SA rate in Aβ-LTMs by Kv7 channel activation with retigabine (6 mg/kg, i.v.) suggesting that Kv7/M channels may be involved in mechanisms of SA generation in Aβ-LTMs, (c) decreases in AP duration and in duration and amplitude of afterhyperpolarization (AHP) in C-and/or Aβ-nociceptors. These faster AP and AHP kinetics may lead to repetitive firing and an increase in afferent input to the CNS and thereby contribute to DPNP development, and (d) a decrease in the electrical thresholds of Aβ-nociceptors that may contribute to their sensitization, and thus to the resulting hypersensitivity associated with DPNP.
Copyright © 2020 Djouhri, Zeidan, Abd El-Aleem and Smith.

Entities:  

Keywords:  K+ channels; action potential; diabetic neuropathy; nociception; primary sensory neurons

Year:  2020        PMID: 32528247      PMCID: PMC7263321          DOI: 10.3389/fnins.2020.00530

Source DB:  PubMed          Journal:  Front Neurosci        ISSN: 1662-453X            Impact factor:   4.677


  55 in total

1.  Conduction slowing in diabetic distal polyneuropathy.

Authors:  David N Herrmann; Michele L Ferguson; Eric L Logigian
Journal:  Muscle Nerve       Date:  2002-08       Impact factor: 3.217

2.  Intra-axonal recording from large sensory myelinated axons: demonstration of impaired membrane conductances in early experimental diabetes.

Authors:  Jasna Kriz; Ante L Padjen
Journal:  Diabetologia       Date:  2003-02-18       Impact factor: 10.122

3.  Hyperpolarization-activated cyclic nucleotide-gated channels contribute to spontaneous activity in L4 C-fiber nociceptors, but not Aβ-non-nociceptors, after axotomy of L5-spinal nerve in the rat in vivo.

Authors:  Laiche Djouhri; Trevor Smith; Ahmad Ahmeda; Mohammad Alotaibi; Xiechuan Weng
Journal:  Pain       Date:  2018-07       Impact factor: 6.961

4.  Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function.

Authors:  D Claus; C Mustafa; W Vogel; M Herz; B Neundörfer
Journal:  Muscle Nerve       Date:  1993-07       Impact factor: 3.217

5.  Blocking of cytokines signalling attenuates evoked and spontaneous neuropathic pain behaviours in the paclitaxel rat model of chemotherapy-induced neuropathy.

Authors:  S Al-Mazidi; M Alotaibi; T Nedjadi; A Chaudhary; M Alzoghaibi; L Djouhri
Journal:  Eur J Pain       Date:  2017-12-27       Impact factor: 3.931

Review 6.  Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment.

Authors:  Ralf Baron; Andreas Binder; Gunnar Wasner
Journal:  Lancet Neurol       Date:  2010-08       Impact factor: 44.182

7.  Streptozotocin-induced early thermal hyperalgesia is independent of glycemic state of rats: role of transient receptor potential vanilloid 1(TRPV1) and inflammatory mediators.

Authors:  Mahendra Bishnoi; Christine A Bosgraaf; Mruvil Abooj; Linlin Zhong; Louis S Premkumar
Journal:  Mol Pain       Date:  2011-07-27       Impact factor: 3.395

Review 8.  Modeling type 2 diabetes in rats using high fat diet and streptozotocin.

Authors:  Søs Skovsø
Journal:  J Diabetes Investig       Date:  2014-05-19       Impact factor: 4.232

Review 9.  M-type K+ channels in peripheral nociceptive pathways.

Authors:  Xiaona Du; Haixia Gao; David Jaffe; Hailin Zhang; Nikita Gamper
Journal:  Br J Pharmacol       Date:  2017-09-17       Impact factor: 8.739

10.  Comparing the effects of isoflurane and pentobarbital on the responses of cutaneous mechanoreceptive afferents.

Authors:  Ju-Wen Cheng; Alison I Weber; Sliman J Bensmaia
Journal:  BMC Anesthesiol       Date:  2013-05-10       Impact factor: 2.217

View more
  4 in total

1.  Painful diabetic neuropathy leads to functional CaV3.2 expression and spontaneous activity in skin nociceptors of mice.

Authors:  Tal Hoffmann; Katrin Kistner; Sonja L J Joksimovic; Slobodan M Todorovic; Peter W Reeh; Susanne K Sauer
Journal:  Exp Neurol       Date:  2021-08-25       Impact factor: 5.330

2.  Electrophysiological Alterations Driving Pain-Associated Spontaneous Activity in Human Sensory Neuron Somata Parallel Alterations Described in Spontaneously Active Rodent Nociceptors.

Authors:  Robert Y North; Max A Odem; Yan Li; Claudio Esteves Tatsui; Ryan M Cassidy; Patrick M Dougherty; Edgar T Walters
Journal:  J Pain       Date:  2022-03-12       Impact factor: 5.383

Review 3.  Cutaneous pain in disorders affecting peripheral nerves.

Authors:  Cheryl L Stucky; Alexander R Mikesell
Journal:  Neurosci Lett       Date:  2021-10-01       Impact factor: 3.046

4.  Chronic BDNF simultaneously inhibits and unmasks superficial dorsal horn neuronal activity.

Authors:  Sascha R A Alles; Max A Odem; Van B Lu; Ryan M Cassidy; Peter A Smith
Journal:  Sci Rep       Date:  2021-01-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.